Correction to: Guidelines for the management of myocardial infarction/injury with non-obstructive coronary arteries (MINOCA): a position paper from the Dutch ACS working group

Pustjens, Tobias; Appelman, Yolande; Damman, Peter; Berg, J. M. ten; Jukema, J. Wouter; Winter, Robbert J. de; Agema, Willem R.P.; Wielen, M. L. J. van der; Arslan, Fatih; Rasoul, Saman; Hof, Arnoud W J van ‘t

doi:10.1007/s12471-019-01358-0

Cited by 4 publications

(19 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The sample size was calculated at 80% power with marginal error of 5%. According to the literature there is a 15% possibility of normal CAG in patients undergoing coronary angiography this will equate to a sample size of 15 patients per arm for paired T test comparing the two group means [1] [2] [3]. Data was collected using a structured questionnaire present in an excel spreadsheet that included: demographics (age, gender and ethnicity), previous risk factors for cardiac disease, laboratory findings (Low Density Lipoprotein value, Hemoglobin-A1C, and highest Hs-troponin value), and CAG finding.…”

Section: This Is a Cohort Of Patients Admitted Between 1st Of April 2018 Through 31st Of World Journal Of Cardiovascular Diseasesmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

“…Acute coronary syndrome with normal or near normal coronary arteries, commonly known as Myocardial Infarction/Injury with Non-obstructive Coronary Arteries (MINOCA), can be caused by many etiologies like coronary disorders, myocardial disorders, or non-cardiac disorders [1] [2] [3]. These etiologies include: coronary spasm, microvascular dysfunction, myocarditis, hypertensive heart disease, stroke, sepsis, and pulmonary embolism [1] [4]. All these conditions result in rise of cardiac enzymes; thus, the challenge arises in making a decision whether the patient is suffering myocardial injury, ischemic infarction requiring further cardiac intervention [1].…”

Section: Introductionmentioning

confidence: 99%

“…These etiologies include: coronary spasm, microvascular dysfunction, myocarditis, hypertensive heart disease, stroke, sepsis, and pulmonary embolism [1] [4]. All these conditions result in rise of cardiac enzymes; thus, the challenge arises in making a decision whether the patient is suffering myocardial injury, ischemic infarction requiring further cardiac intervention [1]. These challenging situations have increased currently with the introduction of high sensitivity cardiac troponin assay in view of its low specificity [1].…”

Section: Introductionmentioning

confidence: 99%

“…All these conditions result in rise of cardiac enzymes; thus, the challenge arises in making a decision whether the patient is suffering myocardial injury, ischemic infarction requiring further cardiac intervention [1]. These challenging situations have increased currently with the introduction of high sensitivity cardiac troponin assay in view of its low specificity [1]. In a review article by Pasupathy et al, the prevalence of MINOCA was reported as 6%, ranging from 1% -15%.…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

New Cutoff for High Sensitivity Troponin to Better Risk Stratify Patients with Non-ST Elevated Myocardial Infarction

Al-Assaf¹,

Musa²,

Alkazim³

et al. 2021

WJCD

View full text Add to dashboard Cite

Background: The diagnosis of Non-ST Elevated Myocardial Infarction (NSTEMI) is dependent on elevation of high sensitivity troponin (Hs-troponin). The current cutoff point for Hs-troponin is highly sensitive but not specific for obstructive coronary artery disease (CAD). This study aims to determine the best cutoff point for diagnosing CAD in patients presented with NSTEMI. Methods: Our study included all patients admitted as NSTEMI that underwent coronary angiography (CAG). They were grouped into two groups: A and B. Group A has obstructive CAD of 70% or more stenosis and group B with non-obstructive CAD. Patients were assessed for their demographics, clinical history, laboratory and imaging results. Using SPSS version 22, the pooled cohort of patients were analyzed at significant level < 0.05 and the data were tested for significant correlations between two predetermined groups. Results: Group A comprised 87.6% of the patients and both groups had a median age of 53 years. In Group A, 91% were males, 54% diabetics, 54% hypertensives, and median Hs-troponin was 145 ng/L. While in group B, 88% were males, 39% diabetics, 60% hypertensives, and median Hs-troponin was 54 ng/L. There was significant correlation between the two groups in the percentage of diabetes and median troponin level (p < 0.05). A ROC curve has identified a level of 127 ng/dL as the best cutoff of Hs-troponin in detecting obstructive CAD (p = 0.03). Interestingly, 60% of patients in group B had alternative diagnoses. Conclusion: Hs-troponin is sensitive but less specific for obstructive CAD. However, increasing its cutoff value will improve its specificity.

show abstract

Section: This Is a Cohort Of Patients Admitted Between 1st Of April 2018 Through 31st Of World Journal Of Cardiovascular Diseasesmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

New Cutoff for High Sensitivity Troponin to Better Risk Stratify Patients with Non-ST Elevated Myocardial Infarction

Al-Assaf¹,

Musa²,

Alkazim³

et al. 2021

WJCD

View full text Add to dashboard Cite

show abstract

Myocardial Infarction With Nonobstructive Coronary Arteries

Polyak

Frishman

2020

Cardiology in Review

View full text Add to dashboard Cite

Myocardial infarction with nonobstructive coronary arteries (MINOCA) is the current term used to describe patients who have a myocardial infarction but have normal, non-obstructed coronary arteries on a coronary angiogram. There is still much debate over the definition, diagnosis, management and treatment of MINOCA. However, MINOCA is not a benign condition; prompt recognition and diagnosis can lead to better management and treatment and thus improve patient outcomes. This review article will update the most recent definition of MINOCA, discuss epidemiology and etiology, and review the diagnostic workup and management options for patients presenting with signs and symptoms of MINOCA.

show abstract

Fisiopatología y algoritmo diagnóstico y terapéutico del MINOCA

Ricarte-Bratti

Bono

Barcudi³

2023

Rev Fac Cien Med Univ Nac Cordoba

View full text Add to dashboard Cite

MINOCA es un síndrome que abarca varias patologías y que ocurre en el contexto clínico de un Síndrome Coronario Agudo. Su incidencia varía de acuerdo con la población estudiada, métodos de diagnósticos utilizados y si han incluido a la Miocarditis y Síndrome de Takotsubo, los cuáles, fueron excluidos recientemente de la definición de MINOCA. Por esta razón, consideramos que la novedad de esta publicación es la no inclusión de estas dos patologías y, por lo tanto, el objetivo de la presente revisión es actualizar este síndrome de forma concisa. También se aborda el manejo de los tres tipos de MINOCA, cuyo diagnóstico se basa fundamentalmente en la utilización de imágenes complementarias específicas, ya que la coronariografia tiene sus limitaciones. El tratamiento será en general farmacológico de acuerdo con el mecanismo fisiopatológico involucrado.

show abstract

Correction to: Guidelines for the management of myocardial infarction/injury with non-obstructive coronary arteries (MINOCA): a position paper from the Dutch ACS working group

Cited by 4 publications

References 0 publications

New Cutoff for High Sensitivity Troponin to Better Risk Stratify Patients with Non-ST Elevated Myocardial Infarction

New Cutoff for High Sensitivity Troponin to Better Risk Stratify Patients with Non-ST Elevated Myocardial Infarction

Myocardial Infarction With Nonobstructive Coronary Arteries

Fisiopatología y algoritmo diagnóstico y terapéutico del MINOCA

Contact Info

Product

Resources

About